Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by FacBineon Dec 09, 2019 10:39am
72 Views
Post# 30435652

RE:RE:RE:RE:StageZero - Oncore Pharma

RE:RE:RE:RE:StageZero - Oncore Pharma Lesson 3: BASHERS POST MANY TIMES A DAY. They try to wear you out. They comment on everything, every other post, and can answer every question. THEY KNOW IT ALL! There is no positive comment they won't Bash. They try to control the board. True longs may have to confront the Bashers or they will appear to the newbies as being the people with all the information. This is best accomplished by posting positive, well researched data on the company, repetitively, while trying hard not to engage the Bashers in direct repartee. REMEMBER - LONGS... RESIST USING THE BASHERS ALIAS! Read more at: https://messageboardfools.com/bashers.htm
LithLover wrote: It is news but its still 6 months out so will not be valued into current shareprice.  The original news said they would need 6 months to work with sales.  Now maybe they can add these tests without longer delays but in either case we wont be seeing official revenue numbers until the summer.  Tripp has lost all credibility when it comes to foirecasts (profitable by end of year $30 million in revenue etc) so no one is going to believe any press releases unless they are backed by formal filings.  Oncore could add Aristotle and it would be the same effect.  Nothing will move us until a major partnership with a health care company is officially announced and/or we see reported results (not the same ole Tripp speak).  You notice how they mention the 1.7 million tests and the 1 million shares of Oncore.  But again this has no confirmed dollar amounts.  We dont have any information of confirmed sales and we dont know what Oncore is valued at.  This is just speculation and fluff to drive up shareprice so Tripp can do more financing.  I'm afraid the next few months will not be great and we will be waiting 4-6 months to see if Tripp and Oncore can execute.


Bullboard Posts